POSSIBLE MECHANISMS OF HYPERPROLIFERATIVE PROCESSES DEVELOPMENT IN THE ENDOMETRIUM
DOI:
https://doi.org/10.32782/2226-2008-2024-5-11Keywords:
endometrial hyperplasia, apoptosis, hyperproliferation, adenocarcinomaAbstract
In the process of examining certain mechanisms of the onset of hyperproliferative processes and their localization and transition to a state of carcinogenesis in the endometrium, specific issues are considered in detail in the literature. The aim of the work is to study the features and characteristics of the endometrial cell response at the current level of research. Materials and methods. A search for original review articles was conducted in online resources and journals to analyze and substantiate certain features presented in Scopus, PubMed, Medline, Web of Science and Google Scholar. This analysis covers the period from 2018 to 2023. Research results. As a result of the analysis, numerous disorders occurring in affected women were identified. In the literature sources, disorders are extensively described both within living cells and in relation to their development across all organs and systems. These changes in organism contribute to the growth and development of carcinogenesis.
References
Abdullaiev VE, Hryhorenko AM. Features of instrumental research methods in combination of endometrial hyperplasia with chronic endometritis. The Bulletin of Vinnytsia National Medical University. 2021; 25(4): 623–627. doi: 10.31393/reportsvnmedical-2021-25(4)-20 (in Ukrainian).
Abrão F, Modotti WP, Spadoto-Dias D, et al. Concomitant p53 and PTEN immunoexpression to predict the risk of malignancy in endometrial polyps. Medicine (Baltimore). 2018; 97(38): e12304. doi: 10.1097/MD.0000000000012304. PMID: 30235677; PMCID: PMC6160221.
Adomaitienė L, Nadišauskienė R, Nickkho-Amiry M, Čižauskas A, Palubinskienė J, Holland C, Seif MW. Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation. Medicina (Kaunas). 2019; 55(9): 543. doi: 10.3390/medicina55090543. PMID: 31466367; PMCID: PMC6780687.
Assaf MI, Abd El-Aal W, Mohamed SS, Yassen NN, Mohamed EA. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma. Asian Pac J Cancer Prev. 2018; 19(8): 2291–2297. doi: 10.22034/APJCP.2018.19.8.2291. PMID: 30139240; PMCID: PMC6171378.
Banz-Jansen C, Helweg LP, Kaltschmidt B. Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go? Int J Mol Sci. 2022; 23(6): 3412. doi: 10.3390/ijms23063412. PMID: 35328833; PMCID: PMC8955970.
Ceci C, Atzori MG, Lacal PM, Graziani G. Role of VEGFs/VEGFR-1 Signaling and its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models. Int J Mol Sci. 2020; 21(4): 1388. doi: 10.3390/ijms21041388. PMID: 32085654; PMCID: PMC7073125.
Chiu HC, Li CJ, Yiang GT, Tsai AP, Wu MY. Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis. J Clin Med. 2019; 8(4): 439. doi: 10.3390/jcm8040439. PMID: 30935077; PMCID: PMC6518354.
Chumak ZV, Shapoval MV, Andrievskiy OG. Hif-1α and IGF Expression in Endometrial Hyperplasia. Journal of Education, Health and Sport. Sport. 2020; 10(11): 61–68. eISSN 2391-8306. http://dx.doi.org/10.12775/JEHS.2020.10.11.006.
Chumak ZV. Shapoval MV, Artyomenko VV. Age-related relationship between the development of hyperplastic processes and VEGF expression in endometrial cells. Journal of Education, Health and Sport. 2020; 10(4): 209–217. eISSN 2391-8306. http://dx.doi.org/10.12775/JEHS.2020.10.04.023.
Dai W, Guo R, Na X, et al. Hypoxia and the endometrium: An indispensable role for HIF-1α as therapeutic strategies. Redox Biol. 2024; 73: 103205. doi: 10.1016/j.redox.2024.103205. PMID: 38815332; PMCID: PMC11167393.
Devis-Jauregui L, Eritja N, Davis ML, Matias-Guiu X, Llobet-Navàs D. Autophagy in the physiological endometrium and cancer. Autophagy. 2021; 17(5): 1077–1095. doi: 10.1080/15548627.2020.1752548. PMID: 32401642; PMCID: PMC8143243.
Ding B, Jinyuan T, Tao K, Ding Z, Yang S. A pilot and ex-vivo study of examination of endometrium tissue by catheter based optical coherence tomography. BMC Med Imaging. 2022; 22(1): 162. doi: 10.1186/s12880-022-00890-7. PMID: 36088282; PMCID: PMC9464373.
Doherty MT, Sanni OB, Coleman HG et al. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis. PLoS One. 2020; 15(4): e0232231. doi: 10.1371/journal.pone.0232231. PMID: 32343732; PMCID: PMC7188276.
Ge QL, Liu SH, Ai ZH, et al. RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis. Cell Death Dis. 2016; 7(10): e2402. doi: 10.1038/cddis.2016.309. PMID: 27711077; PMCID: PMC5133976.
Garashova MA, Alieva EM, Mammadova LD. Сlinical and diagnostic features of endometrial hyperplastic. The World of Medicine and Biology. 2021: 2(76): 23–28. http://dx.doi.org/10.26724/2079-8334-2021-2-76-23-28.
Ghalib Farhood R, Abd Ali Al-Humairi I. Immunohistochemical Study of Ki-67 in Hyperplastic and Endometrium Carcinoma: A Comparative Study. Arch Razi Inst. 2022; 77(1): 229–234. doi: 10.22092/ARI.2021.356540.1865. PMID: 35891746; PMCID: PMC9288597.
Gladchuk IZ, Rozhkovska NM, Kozhakov VL, et al. Intra- and early postoperative results of biopsy of signal lymph node under control of icg mapping in patients with endometrial cancer of initial stages. Scientific digest of association of obstetricians and gynecologists of Ukraine. 2023; 2(52): 11–16. https://doi.org/10.35278/2664-0767.2(52).2023.298039 (in Ukrainian).
Huang M, Liu C, Shao Y, et al. Anti-tumor pharmacology of natural products targeting mitosis. Cancer Biol Med. 2022; 19(6): 774–801. doi: 10.20892/j.issn.2095-3941.2022.0006. PMID: 35699421; PMCID: PMC9257311.
Jain V, Chodankar RR, Maybin JA, Critchley HOD. Uterine bleeding: how understanding endometrial physiology underpins menstrual health. Nat Rev Endocrinol. 2022; 18(5): 290–308. doi: 10.1038/s41574-021-00629-4. PMID: 35136207; PMCID: PMC9098793.
Jeong JY, Hwang SO, Lee B, et al. Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study. PLoS One. 2020; 15(12): e0243064. doi: 10.1371/journal.pone.0243064. PMID: 33259545; PMCID: PMC7707482.
Khaskhachykh DA, Potapov VO. Immunohistochemical characterization of endometrial hyperplasia compared to secretory endometrium. Actual Problems of Pediatrics, Obstetrics and Gynecology. 2024; 2: 69–80. https://doi.org/10.11603/24116-4944.2023.2.14171 (in Ukrainian).
Li RL, He LY, Zhang Q, et al. HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases. Drug Des Devel Ther. 2020; 14: 4915–4949. doi: 10.2147/DDDT.S274980. PMID: 33235435; PMCID: PMC7680173.
Lv M, Chen P, Bai M, et al. Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma. Cancers (Basel). 2022; 14(24): 6210. doi: 10.3390/cancers14246210. PMID: 36551694; PMCID: PMC9776943.
Ma J, Yao Z, Ma L, et al. Glucose metabolism reprogramming in gynecologic malignant tumors. J Cancer. 2024; 15(9): 2627–2645. doi: 10.7150/jca.91131. PMID: 38577616; PMCID: PMC10988310.
Maenhoudt N, De Moor A, Vankelecom H. Modeling Endometrium Biology and Disease. J Pers Med. 2022; 12(7): 1048. doi: 10.3390/jpm12071048. PMID: 35887546; PMCID: PMC9316888.
Murphy AR, Campo H, Kim JJ. Strategies for modelling endometrial diseases. Nat Rev Endocrinol. 2022; 18(12): 727–743. doi: 10.1038/s41574-022-00725-z. Epub 2022 Sep 1. PMID: 36050476; PMCID: PMC10052865.
Neal AS, Nunez M, Lai T, et al. Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyperplasia. Reprod Sci. 2020; 27(9): 1778–1790. doi: 10.1007/s43032-020-00175-w. PMID: 32124398; PMCID: PMC7395059.
Okuda T, Sekizawa A, Purwosunu Y, et al. Genetics of endometrial cancers. Obstet Gynecol Int. 2010; 2010: 984013. doi: 10.1155/2010/984013. PMID: 20396392; PMCID: PMC2852605.
Poliakova YeM, Lutsenko NS, Haidai NV. Diagnosis of endometrial hyperplasia in routine gynecological practicе. Zaporizhzhia Medical Journal. 2019; 21; 1(112): 95–99. https://www.researchgate.net/publication/332522937.
Popgeorgiev N, Jabbour L, Gillet G. Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins. Front Cell Dev Biol. 2018; 6: 13. doi: 10.3389/fcell.2018.00013. PMID: 29497611; PMCID: PMC5819560.
Popli P, Sun AJ, Kommagani R. The Multifaceted Role of Autophagy in Endometrium Homeostasis and Disease. Reprod Sci. 2022; 29(4): 1054–1067. doi: 10.1007/s43032-021-00587-2. PMID: 33877643; PMCID: PMC9423733.
Rubinstein MM, Brown KA, Iyengar NM. Targeting obesity-related dysfunction in hormonally driven cancers. Br J Cancer. 2021; 125(4): 495–509. doi: 10.1038/s41416-021-01393-y. PMID: 33911195; PMCID: PMC8368182.
Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017; 23(2): 232–254. doi: 10.1093/humupd/dmw042. PMID: 27920066; PMCID: PMC5850217.
Taheri M, Ghafouri-Fard S, Najafi S, et al. Hormonal regulation of telomerase activity and hTERT expression in steroidregulated tissues and cancer. Cancer Cell Int. 2022; 22(1): 258. doi: 10.1186/s12935-022-02678-9. PMID: 35974340; PMCID: PMC9380309.
Thakur L, Thakur S. The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions. Front Endocrinol (Lausanne). 2023; 14: 1166948. doi: 10.3389/fendo.2023.1166948. PMID: 37152960; PMCID: PMC10161733.
Tsyndrenko N, Lyndіn M, Sikora K, Wireko AA, Abdul-Rahman T, Hyriavenko N, Romaniuk A. ER and COX2 expression in endometrial hyperplasia processes. Medicine (Baltimore). 2023; 102(33): e34864. doi: 10.1097/MD.0000000000034864. PMID: 37603513; PMCID: PMC10443758.
Urick ME, Bell DW. Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer. 2019; 19(9): 510–521. doi: 10.1038/s41568-019-0177-x. PMID: 31388127; PMCID: PMC7446243.
Vermij L, Smit V, Nout R, Bosse T. Incorporation of molecular characteristics into endometrial cancer management. Histopathology. 2020; 76(1): 52–63. doi: 10.1111/his.14015. PMID: 31846532; PMCID: PMC6972558.
Yu K, Huang ZY, Xu XL, Li J, Fu XW, Deng SL. Estrogen Receptor Function: Impact on the Human Endometrium. Front Endocrinol (Lausanne). 2022; 13: 827724. doi: 10.3389/fendo.2022.827724. PMID: 35295981; PMCID: PMC8920307.
Zhang J, Wang Z, Zhao R, et al. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer. BMC Cancer. 2020; 20(1): 1030. doi: 10.1186/s12885-020-07535-4. PMID: 33109128; PMCID: PMC7590615.
Zhu N, Yang X, Liu Q, et al. “Iron triangle” of regulating the uterine microecology: Endometrial microbiota, immunity and endometrium. Front Immunol. 2022; 13: 928475. doi: 10.3389/fimmu.2022.928475. PMID: 36016947; PMCID: PMC9396262.
